Oncology and Hematology

Episodes 1-16 of 390

ADT Monotherapy for mHSPC: How to Identify the Right Patients
ADT Monotherapy for mHSPC: How to Identify the Right Patients
Global Oncology Academy
ADT Monotherapy for mHSPC: How to Identify the Right Patients
- Daniel J. George, MD
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
Global Oncology Academy
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
- Daniel J. George, MD
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Global Oncology Academy
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
- Daniel J. George, MD
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
Global Oncology Academy
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
- Megan Kruse, MD
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
Global Oncology Academy
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
- Megan Kruse, MD
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Project Oncology®
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Global Oncology Academy
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
- Laura Cappelli, MD, MHS,MS
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Clinician's Roundtable
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
- Ihtisham Ahmad
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Project Oncology®
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Clinician's Roundtable
Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
- Brian P. McDonough, MD, FAAFP
- Carolyn Rutter, PhD
- Gloria Coronado, PhD
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Clinician's Roundtable
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Global Oncology Academy
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
- Paolo Tarantino, MD
Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
Project Oncology®
Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
- Jennifer Caudle, DO
- Doris M. Ponce, MD, MS
Addressing Barriers to Colorectal Cancer Screening in Rural Populations
Addressing Barriers to Colorectal Cancer Screening in Rural Populations
Clinician's Roundtable
Addressing Barriers to Colorectal Cancer Screening in Rural Populations
- Peter Buch, MD, FACG, AGAF, FACP
- Michael Dougherty, MD
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Global Oncology Academy
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
- Paolo Tarantino, MD
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Clinician's Roundtable
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
- Peter Buch, MD, FACG, AGAF, FACP
- A. Mark Fendrick, MD